The cutting-edge technology has no significant side effects, but also happens to have almost no measurable effects of any kind: Tumors don’t shrink. Blood tests are unchanged. But men with otherwise intractable prostate cancer who get the procedure tend to live a bit longer —4.1 months is the median.
And it’s very, very expensive — about $93,000 for a course of treatment.
via cnbc.com
No comments:
Post a Comment